Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Geriatric depression: brain imaging correlates and pharmacologic considerations

W C Drevets1

  • 1Department of Psychiatry, Washington University School of Medicine, St. Louis, Mo 63110-1093.

The Journal of Clinical Psychiatry
|September 1, 1994
PubMed
Summary

Geriatric major depression requires special considerations due to neuropathologic changes, potentially linked to arteriosclerosis or genetics. Newer antidepressants offer safer treatment options for elderly patients with depression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacological characterization of the selective orexin-1 receptor antagonist JNJ-61393215 in healthy volunteers.

Journal of psychopharmacology (Oxford, England)·2023
Same author

Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group.

Molecular psychiatry·2017
Same author

Serum kynurenic acid is reduced in affective psychosis.

Translational psychiatry·2017
Same author

Functional neuroimaging of sex differences in autobiographical memory recall in depression.

Psychological medicine·2017
Same author

The MCP-4/MCP-1 ratio in plasma is a candidate circadian biomarker for chronic post-traumatic stress disorder.

Translational psychiatry·2017
Same author

Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants.

Translational psychiatry·2016

Area of Science:

  • Geriatric Psychiatry
  • Neuroscience
  • Pharmacology

Background:

  • Geriatric major depression presents unique challenges in its etiopathophysiology, pharmacokinetics, and pharmacodynamics.
  • Neuropathologic changes in elderly individuals with depression are increasingly recognized, questioning the view of it being solely a functional disorder.

Purpose of the Study:

  • To explore the neuropathologic underpinnings of geriatric depression.
  • To examine the influence of these changes on antidepressant treatment efficacy and safety in the elderly.
  • To highlight advancements in pharmacotherapy for geriatric depression.

Main Methods:

  • Review of modern brain imaging and postmortem studies.
  • Analysis of pharmacokinetic and pharmacodynamic alterations in geriatric patients.

Related Experiment Videos

  • Evaluation of newer antidepressant agents' safety and efficacy profiles.

    • Main Results:

    • Late-onset depression may be associated with arteriosclerotic changes, while early-onset depression might have genetic roots with superimposed degenerative changes.
    • Neuropathologic changes increase the risk of central nervous system (CNS) adverse effects from antidepressants.
    • Newer antidepressants, such as serotonin selective reuptake inhibitors (SSRIs), venlafaxine, and nefazodone, exhibit reduced CNS and cardiovascular toxicity.

    Conclusions:

    • Geriatric depression is complex, influenced by both functional and organic neuropathologic factors.
    • Understanding these changes is crucial for managing adverse drug reactions in elderly patients.
    • Advances in antidepressant pharmacology provide safer and more effective treatment options for geriatric depression.